Victory Capital Management Inc. Has $16.51 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Victory Capital Management Inc. decreased its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 18.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 186,870 shares of the company's stock after selling 41,703 shares during the period. Victory Capital Management Inc. owned 0.22% of HealthEquity worth $16,514,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in HQY. Ameritas Investment Partners Inc. increased its position in shares of HealthEquity by 0.3% during the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock valued at $3,248,000 after purchasing an additional 88 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in shares of HealthEquity by 0.6% during the 4th quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company's stock valued at $1,850,000 after purchasing an additional 106 shares during the period. Hancock Whitney Corp increased its position in shares of HealthEquity by 1.0% during the 4th quarter. Hancock Whitney Corp now owns 13,326 shares of the company's stock valued at $1,279,000 after purchasing an additional 133 shares during the period. Xponance Inc. increased its position in shares of HealthEquity by 1.1% during the 1st quarter. Xponance Inc. now owns 12,412 shares of the company's stock valued at $1,097,000 after purchasing an additional 136 shares during the period. Finally, Level Four Advisory Services LLC increased its position in shares of HealthEquity by 5.3% during the 4th quarter. Level Four Advisory Services LLC now owns 2,736 shares of the company's stock valued at $263,000 after purchasing an additional 138 shares during the period. Institutional investors own 99.55% of the company's stock.

HealthEquity Trading Up 1.8%

NASDAQ:HQY traded up $1.66 during trading hours on Friday, hitting $96.04. 497,345 shares of the stock were exchanged, compared to its average volume of 863,282. The company's 50 day moving average is $101.54 and its two-hundred day moving average is $98.43. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $116.65. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $8.31 billion, a P/E ratio of 70.10, a price-to-earnings-growth ratio of 1.46 and a beta of 0.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The firm had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. During the same quarter in the prior year, the business earned $0.80 EPS. On average, sell-side analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

HQY has been the topic of several research analyst reports. JMP Securities lifted their price target on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday, June 4th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. Bank of America lifted their target price on HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. KeyCorp decreased their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Finally, Barrington Research lifted their target price on HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a report on Thursday, June 5th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $118.55.

Insider Activity

In other news, EVP Elimelech Rosner sold 58,000 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the transaction, the executive vice president owned 75,689 shares of the company's stock, valued at $8,519,553.84. This represents a 43.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction on Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the transaction, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. This trade represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 291,744 shares of company stock valued at $32,705,007 in the last 90 days. 1.50% of the stock is owned by company insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.